Adial Pharmaceuticals (ADIL) Debt to Equity (2022)
Adial Pharmaceuticals' Debt to Equity history spans 1 years, with the latest figure at $0.15 for Q4 2022.
- For Q4 2022, Debt to Equity changed N/A year-over-year to $0.15; the TTM value through Dec 2022 reached $0.15, changed N/A, while the annual FY2022 figure was $0.15, N/A changed from the prior year.
- Debt to Equity for Q4 2022 was $0.15 at Adial Pharmaceuticals.
- Across five years, Debt to Equity topped out at $0.15 in Q4 2022 and bottomed at $0.15 in Q4 2022.